期刊文献+

GnRH拮抗剂在卵巢反应不良患者中的应用 被引量:4

The application of gonadotropin-releasing hormone antagonist on the patients with poor ovarian response
原文传递
导出
摘要 目的探讨促性腺激素释放激素(GnRH)拮抗剂在卵巢反应不良患者中的应用。方法对既往应用体外受精-胚胎移植(IVF-ET)技术治疗过程中发生卵巢反应不良或取消周期的60例不孕患者随机对照分为两组,GnRH拮抗剂组和GnRH激动剂方案组,观察激素水平、获卵数、受精率、妊娠率等。结果拮抗剂组获卵数多于激动剂组(3.36±1.97 vs 2.43±0.92,P=0.038),两组患者在HCG日LH水平、E2水平和P水平没有明显差异,在>14mm的卵泡数、妊娠率分别为(3.04±1.33 vs 2.73±0.87,P=0.082)、(24%vs 14.3%,P=0.291),两组患者均没有出现LH峰值。结论GnRH拮抗剂方案对卵巢反应不良的患者不失为可尝试的治疗方法。 Objective : To compare the effect of gonadotropin - releasing hormone antagonist with gonadotropin - releasing hormone agonist on the patients with histories of poor ovarian response or being cancelled. Design : Prospective study. Setting: University hospital. Methods : 60 women with histories of poor ovarian response and being cancelled were divided into group A, who received gonadotropin - releasing hormone antagonist ( n =29 ), and group B, who adopted with gonadotropin - releasing hormone agonist ( n = 31 ). Main Outcome Measure (s) : Oocytes retrieved, serum LH and estradiol levels, maturity of oocytes, fertilization rates, embryo number and quality, and pregnancy rates (PR). Results: 53 patients completed follicle aspirations. No LH surges occurred in two groups. The patients got more oocytes in group A than group B. There are no significant difference in mature follicles, fertilization rate, pregnancy rate and abortion rates, 6 of 25 patients resulted in a clinical pregnancy (24% PR per retrieval) in group A and 4 of 28 patients got pregnancy in group B (14. 3% ). Conclusion: A gonadotropin -releasing hormone antagonist multiple protocol may be the better choice for the treatment of poor ovarian response.
出处 《中国优生与遗传杂志》 2009年第4期118-120,共3页 Chinese Journal of Birth Health & Heredity
关键词 促性腺激素释放素(GnRH) 卵巢反应不良 GnRH Poor ovarian response
  • 相关文献

参考文献12

  • 1甄秀梅,乔杰,李蓉,陈新娜,刘平.体外受精-胚胎移植309个卵巢反应不良周期临床分析[J].中国妇产科临床杂志,2007,8(2):113-116. 被引量:13
  • 2Akman MA,et al. Addition of GnRH antagonist in cycles of poor responders undergoing IVF [ J ]. Hum Reprod,2000,15 : 2145 - 7.
  • 3Fasouliotis SJ, Laufer N, Sabbagh -Ehrlich S, et al. Gonadotropin - releasing hormone (GnRH) - antagonist versus GnRH - agonist in ovarian stimulation of poor responders undergoing IVF [ J ]. J Assist Reprod Genet ,2003,20:455 - 60.
  • 4Copperman AB. Antagonists in poor - responder patients [ J ]. Fertil Steril,2003,80 ( Suppl. 1 ) : S16 - 24. discussion S32 - 4.
  • 5D' Amato G, et al. A novel protocol of ovulation induction with delayed gonadotropin - releasing hormone antagonist administration combined with high - dosed recombinant follicle - stimulating hormone and clomiphene citrate for poor responders and women over 35 years [J]. Fertil and Steril, 2004,81 (6):1572 -1577.
  • 6Lee TH,Wu MY ,Chen HF,et al. Ovarian response and follicular development for single - dose and multiple - dose protocols for gonadotropin releasing hormone antagonist administration [ J ]. Fertil Steril, 2005,83 (6) : 1700 - 1707.
  • 7Nikolettos N, AL - Hasani S, Felberbaum R, et al. Gonadotropin - releasing hormone antagonist protocol : a novel method of ovarian stimulation in poor responders[J]. European Journal of Obstetrics & Gynecology and Reproductive Biology, 2001,97:202 -207.
  • 8Bahceci M, Ulug U, Turan E, et al. Comparisons of follicular levels of sex steroids, gonadotropins and insulin like growth factor - 1 ( IGF - 1 ) and epidermal growth factor(EGF) in poor responder and normoresponder patients undergoing ovarian stimulation with GnRH antagonist[J]. European Journal of Obstetrics & Gynecology and Reproductive Biology,2007,130:93 - 98.
  • 9Biljan MM, et aL Effects of pretreatment with an oral contraceptive on the time required to achieve pituitary suppression with gonadotropin releasing hormone analogues and on subsequent implantation and pregnancy rates [ J ]. Fertil Steril, 1998,70 : 1063 - 9.
  • 10Gonen Y, et al. Gonadotropin suppression with oral contraceptives before in vitro fertilization[ J ]. FertiL Steril, 1990,53:282 - 7.

二级参考文献11

  • 1[1]Faddy MJ,Gosden RG,Gougen A,et al.Accelerated disappearance of ovarian follicles in mid-life:implication for forecasting menophause.Hum Reprod,1992,7:1342-1346.
  • 2[2]Bancsi LJMM,Broekmans FJM,Eijkemans MJC,et al.Predictors of poor ovarian responses in in vitro fertilization:a prospective study comparing basal markers of ovarian reserve.Fertil Steril,2002,77:328-336.
  • 3[3]Akande VA,Fleming CF,Hunt LP,et al.Biological versus chronological ageing of oocytes,distinguishable by raised FSH levels in relation to the success of IVF treatment.Hum Reprod,2002,17:2003-2008.
  • 4[4]Keay SD,Lunenfeld B,Eshel A,et al.Assisted conception following poor ovarian responses to gonadotrophin stimulation.Br J Obstet Gynaecol,1997,14:521-527.
  • 5[5]Faber BM,Mayer J,Cox B,et al.Cessation of gonadotropin-releasing hormone agonist therapy combined with high-dose gonadotropin stimulation yields favorable pregnancy results in low responders.Fertil Steril,1998,69:826-830.
  • 6[6]Surrey ES,Bower J,Hill DM,et al.Clinical and endocrine effects of a microdose GnRH agonist flare regimen administered to poor responders who are undergoing in vitro fertilization.Fertil Steril,1998,69:419-424.
  • 7[7]Lindheim SR,Barad DH,Witt B,et al.Short-term gonadotropin suppression with oral contraceptives benefits poor responders prior to controlled ovarian hyperstimulation.J Assist Reprod Genet,1996,13:745-747.
  • 8[8]Kailasam C,Keay SD,Wilson P,et al.Defining poor ovarian response during IVF cycles,in women aged <40 years,and its relationships with treatment outcome.Hum Reprod,2004,19:1544-1547.
  • 9[9]Schachter M,Friedler S,Raziel A,et al.Improvement of IVF outcome in poor responders by discontinuation of GnRH analogue during the gonadotropin stimulation phase--a function of improved embryo quality.J Assist Reprod Genet,2001,18:197-204.
  • 10[10]Nargund G,Cheng WC,Parsons J.The impact of ovarian cystectomy on ovarian response to stimulation during in vitro fertilization cycles.Hum Reprod,1995,11:81-83.

共引文献34

同被引文献28

  • 1周灿权,钟依平.对超排卵反应不良患者的应对策略[J].实用妇产科杂志,2005,21(8):463-466. 被引量:14
  • 2赵旭,刘平,刘鹏博(编校).控制超排卵中的卵巢低反应[J].中国妇幼保健,2006,21(8):1150-1153. 被引量:12
  • 3De Placido G,Moilo A, Clarizia R, et al. Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizinghormone Vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian resi?onse [ J ]. Ferlil Steril, 2006,85 : 247-250.
  • 4Mahutte NG, Arici A. Role of gonadotropin-releasing hormone antagonists in poor responders [J]. Fertil Steril, 2007,87 : 241-249.
  • 5Juni P, Altman DG,Egger M. Assessing the quality of controlled clinical trials[J]. BMJ ,2001,323:42-46.
  • 6Stroup DF, Berlin JA, Morton SC, et al. Meta-analysis of observational studies epidemiology :a proposal for reporting [J]. JAMA, 2000,283 ( 15 ) :2008-2012.
  • 7Kahraman K, Berker B, Atabekoglu CS, et al. Mierodose gonadotropin-releasing hormone agonisl flare-up protocol versus multiple dose gonadotropin-releasing hormone antagonist protoeolin poor responders undergoing intraeytoplasmie sperm injection-embryo transfer cycle [J]. Fertil Steril, 2009,91 ( 6 ) : 2437-2444.
  • 8Cochrane Reviewer'Handbook 4.1. The Cochrane Collaboration, 2000.
  • 9Schulz KF, Chalmers I, Hayes RJ, et al. Empirical evidence of bias[J]. JAMA, 1995,273:408-421.
  • 10Cheung LP,Lam PM, I.ok IH,et al. GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial [ J ]. Hum Reprod ,2005,20( 3 ) :616-621.

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部